255 related articles for article (PubMed ID: 15073112)
1. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.
Zhang HT; Chen XF; Wang MH; Wang JC; Qi QY; Zhang RM; Xu WQ; Fei QY; Wang F; Cheng QQ; Chen F; Zhu CS; Tao SH; Luo Z
Clin Cancer Res; 2004 Apr; 10(7):2359-67. PubMed ID: 15073112
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
[TBL] [Abstract][Full Text] [Related]
4. Mutation and methylation analysis of the transforming growth factor beta receptor II gene in polycythaemia vera.
Li J; Bench AJ; Huntly BJ; Green AR
Br J Haematol; 2001 Dec; 115(4):872-80. PubMed ID: 11843821
[TBL] [Abstract][Full Text] [Related]
5. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
Jakowlew SB; Moody TW; You L; Mariano JM
Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
[TBL] [Abstract][Full Text] [Related]
6. Infrequently methylated event at sites -362 to -142 in the promoter of TGF beta R1 gene in non-small cell lung cancer.
Zhao J; Liu Z; Li W; Liu X; Chen XF; Zhang HT
J Cancer Res Clin Oncol; 2008 Aug; 134(8):919-25. PubMed ID: 18421475
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
9. Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung.
Kim WS; Park C; Jung YS; Kim HS; Han J; Park CH; Kim K; Kim J; Shim YM; Park K
Anticancer Res; 1999; 19(1A):301-6. PubMed ID: 10226558
[TBL] [Abstract][Full Text] [Related]
10. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
11. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
[TBL] [Abstract][Full Text] [Related]
12. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.
Tani M; Takenoshita S; Kohno T; Hagiwara K; Nagamachi Y; Harris CC; Yokota J
Carcinogenesis; 1997 May; 18(5):1119-21. PubMed ID: 9163705
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.
Franchi A; Gallo O; Sardi I; Santucci M
J Clin Pathol; 2001 Mar; 54(3):201-4. PubMed ID: 11253131
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of transforming growth factor beta receptors I and II in non-small-cell lung tumors.
Colasante A; Aiello FB; Brunetti M; di Giovine FS
Cytokine; 2003 Dec; 24(5):182-9. PubMed ID: 14596814
[TBL] [Abstract][Full Text] [Related]
15. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
Nørgaard P; Spang-Thomsen M; Poulsen HS
Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
[TBL] [Abstract][Full Text] [Related]
16. Resistance to TGF-beta 1 correlates with aberrant expression of TGF-beta receptor II in human B-cell lymphoma cell lines.
Chen G; Ghosh P; Osawa H; Sasaki CY; Rezanka L; Yang J; O'Farrell TJ; Longo DL
Blood; 2007 Jun; 109(12):5301-7. PubMed ID: 17339425
[TBL] [Abstract][Full Text] [Related]
17. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
Carethers JM; Pham TT
In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.
Zheng SY; Hou JY; Zhao J; Jiang D; Ge JF; Chen S
Asian Pac J Cancer Prev; 2012; 13(4):1557-61. PubMed ID: 22799366
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.
de Jonge RR; Garrigue-Antar L; Vellucci VF; Reiss M
Oncol Res; 1997; 9(2):89-98. PubMed ID: 9167190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]